NCT06165562

Brief Summary

This study aims to assess whether pressure supporting ventilation and electroencephalogram (EEG)-guided emergence can reduce airway complications after thyroid surgery compared with conventional emergence. Patients will be randomly assigned to either pressure supporting ventilation and EEG-guided emergence group (intervention group) or conventional emergence group (control group). Co-primary outcomes are the incidence of emergence coughing and lowest percutaneous oxygen saturation (SpO2) after emergence. Secondary outcomes included severity of emergence cough, emergence time, blood pressure and heart rate during emergence, Richmond Agitation-Sedation Scale (RASS) immediately after extubation and upon post-anesthesia care unit (PACU) arrival, incidence of desaturation during PACU stay, hoarseness, sore throat during PACU stay, duration of PACU stay, surgeon satisfaction regarding emergence process, postoperative pain score, and patient satisfaction score regarding emergence process.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 16, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

December 11, 2023

Completed
25 days until next milestone

Study Start

First participant enrolled

January 5, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

March 12, 2024

Status Verified

March 1, 2024

Enrollment Period

12 months

First QC Date

November 16, 2023

Last Update Submit

March 8, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Incidence of emergence coughing

    Incidence of emergence coughing (defined as coughing during the time period from sevoflurane off until 5 minutes after extubation)

    During the time period from sevoflurane cessation until 5 minutes after extubation

  • Lowest SpO2 after emergence

    Lowest SpO2 after emergence (defined as the lowest SpO2 value during the time period from sevoflurane off to post-anesthesia care unit (PACU) discharge)

    During the time period from sevoflurane cessation until post-anesthesia care unit (PACU) discharge, an average of 1 hour

Secondary Outcomes (21)

  • Severity of Emergence coughing

    During the time period from sevoflurane cessation until 5 minutes after extubation.

  • Incidence and severity of coughing during PACU stay

    During the time period from PACU admission until PACU discharge, an average of 40 minutes

  • Emergence time

    During the time period from sevoflurane cessation until tracheal extubation, an average of 20 minutes

  • Time to leave operating room

    During the time period from sevoflurane cessation until leaving operating room, an average of 30 minutes

  • Blood pressure during emergence

    during the time period from sevoflurane off until 5 minutes after extubation

  • +16 more secondary outcomes

Study Arms (2)

Pressure Supporting Ventilation (PSV) and EEG-guided Emergence group

EXPERIMENTAL

Pressure support ventilation will be applied from the start of subcutaneous suture until extubation. At the end of surgery, sevoflurane will be discontinued, and the attending anesthesiologist will perform tracheal extubation after observing the 'zipper opening' pattern on the EEG spectrogram, indicating the patient's recovery of consciousness. For safety reason, extubation will also be guided by the following processed EEG indices thresholds: 1. 95% spectral edge frequency (SEF) ≥ 23 2. Patient state index (PSI) ≥ 64

Procedure: PSVProcedure: EEG-GuidanceProcedure: Spontaneous Respiration

Conventional Emergence group

ACTIVE COMPARATOR

Conventional full-awake extubation will be performed based on the routine practice of our institution. At the end of surgery, sevoflurane will be stopped, and the attending anesthesiologist will lead the emergence process, allowing the patient to breathe spontaneously and providing intermittent manual assistance if necessary. Extubation will be performed when the patient meets the following criteria: obeys commands such as eye-opening or hand-grip, tidal volume \> 5 ml/kg, end-tidal carbon dioxide \< 45 mmHg, spontaneous respiratory rate 10 to 20 breaths/min.

Procedure: Intermittent Manual AssistanceProcedure: Obey CommandProcedure: Spontaneous Respiration

Interventions

PSVPROCEDURE

Pressure support ventilation applied from the start of subcutaneous suture until extubation.

Pressure Supporting Ventilation (PSV) and EEG-guided Emergence group

Volume-controlled mode during surgery, with intermittent manual assistance from the end of surgery until extubation.

Conventional Emergence group
EEG-GuidancePROCEDURE

Extubation criteria based on EEG findings:Zipper opening pattern observed in the spectrogram 95% spectral edge frequency (SEF) ≥ 23 Patient state index (PSI) ≥ 64

Pressure Supporting Ventilation (PSV) and EEG-guided Emergence group
Obey CommandPROCEDURE

Extubation criteria include obeying commands (eye-opening or handgrip).

Conventional Emergence group

Extubation criteria include: Tidal volume \> 5 ml/kg End-tidal carbon dioxide (ETCO2) \< 45 mmHg Spontaneous respiratory rate (RR) 10 to 20 breaths/min

Conventional Emergence groupPressure Supporting Ventilation (PSV) and EEG-guided Emergence group

Eligibility Criteria

Age19 Years - 39 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patients aged under 40 years who are scheduled to undergo thyroid surgery.

You may not qualify if:

  • Patients scheduled for radical neck dissection
  • Patients scheduled for lymph node biopsy
  • Patients with an anticipated difficult airway
  • Patients experiencing difficulty during intubation
  • Patients with a fasting time not meeting institutional policy
  • Patients with a body mass index (BMI) greater than 30 kg/m²
  • Patients with sleep apnea
  • Pregnant or breastfeeding women
  • Patients unable to communicate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gangnam Severance Hospital

Seoul, South Korea

RECRUITING

Related Publications (3)

  • Difficult Airway Society Extubation Guidelines Group; Popat M, Mitchell V, Dravid R, Patel A, Swampillai C, Higgs A. Difficult Airway Society Guidelines for the management of tracheal extubation. Anaesthesia. 2012 Mar;67(3):318-40. doi: 10.1111/j.1365-2044.2012.07075.x.

    PMID: 22321104BACKGROUND
  • Purdon PL, Pierce ET, Mukamel EA, Prerau MJ, Walsh JL, Wong KF, Salazar-Gomez AF, Harrell PG, Sampson AL, Cimenser A, Ching S, Kopell NJ, Tavares-Stoeckel C, Habeeb K, Merhar R, Brown EN. Electroencephalogram signatures of loss and recovery of consciousness from propofol. Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):E1142-51. doi: 10.1073/pnas.1221180110. Epub 2013 Mar 4.

    PMID: 23487781BACKGROUND
  • Jeong H, Tanatporn P, Ahn HJ, Yang M, Kim JA, Yeo H, Kim W. Pressure Support versus Spontaneous Ventilation during Anesthetic Emergence-Effect on Postoperative Atelectasis: A Randomized Controlled Trial. Anesthesiology. 2021 Dec 1;135(6):1004-1014. doi: 10.1097/ALN.0000000000003997.

    PMID: 34610099BACKGROUND

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Patients, medical staff responsible for measuring outcome variables, surgeons, and nurses in the recovery room and wards will be blinded. This blinding approach ensures that both medical staff and patients remain unaware of the assigned group throughout the study.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Prospective, single-blinded, parallel-group, randomized clinical study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associcate Professor

Study Record Dates

First Submitted

November 16, 2023

First Posted

December 11, 2023

Study Start

January 5, 2024

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

March 12, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations